← Back to Clinical Trials
Recruiting NCT07531771

NCT07531771 Comparative Effect of Pursed Lip Breathing Alone and Combined With Alternate Nostril Breathing on Pulmonary Function Test and Quality of Life in Patients in Grade I COPD Patients.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07531771
Status Recruiting
Phase
Sponsor Foundation University Islamabad
Condition COPD Grade I
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2026-02-28
Primary Completion 2026-05-15

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
pursed lip breathingAlternate Nostril breathing:

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2026-02-28 with a primary completion date of 2026-05-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory disorder characterized by airflow limitation, breathlessness, and reduced quality of life. Breathing exercises are commonly used in pulmonary rehabilitation to improve respiratory efficiency and functional capacity. Among these techniques, pursed lip breathing (PLB) helps slow expiration, reduce air trapping, and improve ventilation, while alternate nostril breathing (ANB), a yogic breathing technique, may enhance respiratory control and relaxation. The purpose of this study is to determine the effects of pursed lip breathing alone compared with the combined effect of pursed lip breathing and alternate nostril breathing on pulmonary function and quality of life in patients with Grade I COPD. This randomized controlled trial will include approximately 40 participants diagnosed with mild COPD. The participants will be divided into two groups: one group will perform pursed lip breathing exercises, while the other group will perform a combination of pursed lip breathing and alternate nostril breathing. Pulmonary function tests and quality of life assessments will be used as outcome measures to evaluate the effectiveness of these interventions. The study aims to determine whether combining both breathing techniques provides greater improvement in respiratory function and patient well being than pursed lip breathing alone. The findings may contribute to developing more effective physiotherapy based pulmonary rehabilitation strategies for patients with COPD.

Eligibility Criteria

Inclusion Criteria: * Patients diagnosed with Grade I COPD (FEV₁ \> 80% predicted) * Age between 40 to 65 years. * Both male and female patients. * Patients able to follow verbal instructions and perform breathing exercises. * Patients willing to provide written informed consent. Exclusion Criteria: * History of orthopedic conditions limiting sitting or breathing exercises. * Recent respiratory infections or COPD exacerbations within the past 4 weeks. * Neurological or cognitive impairments. * Recent thoracic or abdominal surgeries. * Regular practitioners of yoga or alternate nostril breathing.

Contact & Investigator

Central Contact

Haleema Sadia Sultan, MSPT-CPT

✉ sadiaawan798@gmail.com

📞 03325881596

Frequently Asked Questions

Who can join the NCT07531771 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, up to 65 Years, studying COPD Grade I. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07531771 currently recruiting?

Yes, NCT07531771 is actively recruiting participants. Contact the research team at sadiaawan798@gmail.com for enrollment information.

Where is the NCT07531771 trial being conducted?

This trial is being conducted at Islamabad, Pakistan.

Who is sponsoring the NCT07531771 clinical trial?

NCT07531771 is sponsored by Foundation University Islamabad. The trial plans to enroll 40 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology